Brokerages Set INmune Bio, Inc. (NASDAQ:INMB) Price Target at $8.00
INmune Bio, Inc. (NASDAQ:INMB – Get Free Report) has been given a consensus recommendation of “Hold” by the six ratings firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have given a hold recommendation, one has given a buy recommendation and one […]
5 Apr 01:18 · The Cerbat Gem